Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in ChinaYing Chi, Lunbiao Cui, Yiyue Ge et al.|The Journal of Infectious Diseases|2020Cited by 391
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trialJingxin Li, Fengcai Zhu, Lihua Hou et al.|Nature Medicine|2022Cited by 163
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Tao Zhu, Hui Zheng et al.|The Lancet Respiratory Medicine|2023Cited by 58
Heterologous prime-boost immunization with CoronaVac and ConvideciaJingxin Li, Fengcai Zhu, Lihua Hou et al.|medRxiv|2021Cited by 33
Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized TrialRong Tang, Jingxin Li, Hui Zheng et al.|SSRN Electronic Journal|2022Cited by 3